<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000438726"><TermName>TTI-237</TermName><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called mitotic inhibitors.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>TTI-237</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Es un tipo de inhibidor mitótico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-08-24</DateFirstPublished><DateLastModified>2006-11-08</DateLastModified></GlossaryTerm>
